Insider Trading activities of Quest Diagnostics Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quest Diagnostics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Quest Diagnostics Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Quest Diagnostics Inc since 2005. The reporting company's ticker symbol is DGX. The reporting company's CIK number is 1022079.
The total value of stock buying since 2005 is $1,959,690.
The total value of stock sales since 2005 is $2,281,950,516.
The total value of stock option exercises since 2005 is $205,391,210.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Quest Diagnostics Inc insiders (DGX) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-02-09 Baldwin John C Md (Director) Sale 30,000 57.56 1,726,890
2011-02-09 Baldwin John C Md (Director) Option Ex 30,000 45.83 1,374,990
2011-02-09 Mohapatra Surya N (Chairman, President & CEO) Sale 152,000 57.53 8,745,168
2011-02-09 Mohapatra Surya N (Chairman, President & CEO) Option Ex 152,000 35.53 5,400,863
2011-02-08 Ziegler John B (Director) Sale 21,180 58.57 1,240,427
2011-02-08 Ziegler John B (Director) Option Ex 21,180 39.35 833,475
2011-02-07 Hagemann Robert (SVP & Chief Financial Officer) Sale 99,287 58.91 5,849,493
2011-02-07 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 99,287 36.34 3,608,486
2011-02-07 Bongiorno Thomas F (VP and Corporate Controller) Sale 28,729 58.80 1,689,236
2011-02-07 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 23,694 42.06 996,569
2011-02-07 Stanzione Daniel (Director) Sale 20,000 58.92 1,178,320
2011-02-07 Stanzione Daniel (Director) Option Ex 20,000 29.53 590,520
2011-02-07 Wilensky Gail R (Director) Sale 20,000 58.58 1,171,500
2011-02-07 Wilensky Gail R (Director) Option Ex 20,000 29.53 590,520
2011-01-31 Glaxosmithkline Plc Sale 30,755,151 54.96 1,690,241,588
2010-05-03 Hagemann Robert (SVP & Chief Financial Officer) Sale 3,571 57.05 203,732
2010-05-03 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 3,571 24.76 88,417
2010-04-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 3,571 58.66 209,464
2010-04-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 3,571 24.76 88,417
2010-03-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 3,571 57.17 204,164
2010-03-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 3,571 24.76 88,417
2010-02-19 Mohapatra Surya N (Chairman, President & CEO) Sale 150,000 57.27 8,589,750
2010-02-19 Mohapatra Surya N (Chairman, President & CEO) Option Ex 150,000 24.76 3,714,000
2010-02-18 Bongiorno Thomas F (VP and Corporate Controller) Sale 5,197 57.64 299,549
2010-02-18 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 9,552 46.24 441,674
2010-02-03 Hagemann Robert (SVP & Chief Financial Officer) Sale 75,000 56.54 4,240,800
2010-02-03 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 75,000 24.76 1,857,000
2009-11-06 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 21,800 57.70 1,257,860
2009-11-06 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 21,800 35.38 771,393
2009-11-04 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 20,000 56.95 1,139,020
2009-11-04 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 20,000 40.43 808,560
2009-11-04 Simmons Wayne R. (Vice President, Operations) Sale 19,767 56.91 1,124,959
2009-11-04 Simmons Wayne R. (Vice President, Operations) Option Ex 24,000 40.43 970,271
2009-10-23 Simmons Wayne R. (Vice President, Operations) Sale 100 56.50 5,650
2009-10-23 Simmons Wayne R. (Vice President, Operations) Option Ex 120 40.43 4,851
2009-10-23 Bongiorno Thomas F (VP and Corporate Controller) Sale 4,230 56.87 240,577
2009-10-23 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 11,329 35.53 402,553
2009-08-21 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 4,100 55.00 225,500
2009-08-21 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 4,100 24.76 101,516
2009-08-20 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 31,117 54.56 1,697,650
2009-08-20 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 18,400 35.53 653,807
2009-08-17 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 5,514 54.80 302,167
2009-08-13 Mohapatra Surya N (Chairman, President & CEO) Sale 11,236 53.51 601,204
2009-08-13 Mohapatra Surya N (Chairman, President & CEO) Option Ex 11,236 46.89 526,889
2009-08-03 Buehler William F (Director) Sale 20,000 54.13 1,082,700
2009-08-03 Buehler William F (Director) Option Ex 20,000 29.53 590,520
2009-07-29 Prevoznik Michael E (SVP & General Counsel) Sale 68,000 55.12 3,748,228
2009-07-29 Prevoznik Michael E (SVP & General Counsel) Option Ex 68,000 26.07 1,773,100
2009-07-28 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 14,300 56.20 803,660
2009-07-28 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 14,300 24.76 354,068
2009-07-27 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 9,200 56.20 517,040
2009-07-27 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 9,200 26.07 239,890
2009-07-27 Bongiorno Thomas F (VP and Corporate Controller) Sale 3,000 56.00 168,009
2009-07-27 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 3,000 17.58 52,734
2009-07-23 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 4,274 56.00 239,344
2009-07-23 Hagemann Robert (SVP & Chief Financial Officer) Sale 112,218 55.61 6,239,994
2009-07-23 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 81,218 36.98 3,003,116
2009-07-23 Mohapatra Surya N (Chairman, President & CEO) Sale 152,000 55.68 8,463,360
2009-07-23 Mohapatra Surya N (Chairman, President & CEO) Option Ex 152,000 26.07 3,963,400
2009-03-19 Glaxosmithkline Plc (Director) Sale 4,749,157 44.64 212,016,615
2009-03-18 Glaxosmithkline Plc (Director) Sale 500,000 46.04 23,019,000
2009-03-17 Glaxosmithkline Plc (Director) Sale 500,000 45.50 22,749,000
2009-02-24 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 10,000 51.10 511,000
2009-02-24 Wilensky Gail R (Director) Sale 12,000 51.27 615,204
2009-02-24 Wilensky Gail R (Director) Option Ex 12,000 15.03 180,372
2009-02-19 Prevoznik Michael E (SVP & General Counsel) Sale 18,930 50.82 961,965
2009-02-19 Prevoznik Michael E (SVP & General Counsel) Option Ex 18,930 31.73 600,611
2009-02-19 Bongiorno Thomas F (VP and Corporate Controller) Sale 8,644 50.81 439,201
2009-02-19 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 9,200 26.07 239,890
2009-02-18 Bongiorno Thomas F (VP and Corporate Controller) Sale 4,459 50.61 225,669
2009-02-18 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 9,200 26.07 239,890
2009-02-06 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 5,000 52.25 261,250
2009-02-06 Ziegler John B (Director) Sale 20,966 52.01 1,090,357
2009-02-06 Ziegler John B (Director) Option Ex 20,966 32.88 689,445
2009-02-02 Mohapatra Surya N (Chairman, President & CEO) Sale 10,884 49.75 541,479
2009-02-02 Mohapatra Surya N (Chairman, President & CEO) Option Ex 10,884 49.25 536,047
2008-11-13 Haggerty Rosanne (Director) Sale 14,268 45.95 655,614
2008-11-13 Haggerty Rosanne (Director) Option Ex 13,600 45.95 624,920
2008-11-06 Mohapatra Surya N (Chairman, President & CEO) Sale 44,811 46.39 2,078,737
2008-11-06 Mohapatra Surya N (Chairman, President & CEO) Option Ex 44,811 46.39 2,078,737
2008-11-05 Mohapatra Surya N (Chairman, President & CEO) Sale 75,421 47.67 3,595,394
2008-11-05 Mohapatra Surya N (Chairman, President & CEO) Option Ex 75,421 47.67 3,595,394
2007-07-27 Hagemann Robert (Sr. Vice President & CFO) Sale 12,502 55.51 693,948
2007-07-27 Hagemann Robert (Sr. Vice President & CFO) Option Ex 12,502 40.84 510,644
2007-05-09 Ziegler John B Option Ex 2,092 19.88 41,578
2007-02-26 Grant William R (Director) Sale 80,135 51.91 4,159,968
2007-02-26 Grant William R (Director) Option Ex 80,135 15.93 1,276,871
2007-02-23 Grant William R Sale 75,000 52.36 3,927,075
2007-02-23 Grant William R Option Ex 75,000 38.69 2,901,375
2007-02-07 Bongiorno Thomas F (Vice Pres. & Controller) Sale 9,917 52.62 521,862
2007-02-06 Bongiorno Thomas F (Vice Pres. & Controller) Sale 3,385 52.90 179,066
2007-02-06 Bongiorno Thomas F (Vice Pres. & Controller) Option Ex 15,000 17.58 263,670
2006-10-30 Zewe David M (SVP, Diagnostic Testing Ops) Sale 102,000 49.59 5,058,384
2006-10-30 Zewe David M (SVP, Diagnostic Testing Ops) Option Ex 102,000 25.42 2,592,534
2006-10-26 Stanzione Daniel Buy 1,000 49.73 49,726
2006-05-22 Mohapatra Surya N (Chairman, President & CEO) Sale 76,179 57.02 4,343,802
2006-05-22 Mohapatra Surya N (Chairman, President & CEO) Option Ex 84,940 5.67 482,034
2006-05-17 Ziegler John B Sale 5,390 58.70 316,393
2006-05-17 Ziegler John B Option Ex 10,000 15.03 150,310
2006-05-12 Prevoznik Michael E (Senior VP & General Counsel) Sale 36,320 57.88 2,102,165
2006-05-12 Prevoznik Michael E (Senior VP & General Counsel) Option Ex 41,000 6.58 269,985
2006-05-11 Prevoznik Michael E (Senior VP & General Counsel) Sale 6,000 58.03 348,156
2006-05-11 Hagemann Robert (SVP & Chief Financial Officer) Sale 113,468 57.78 6,556,066
2006-05-11 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 127,188 20.69 2,631,138
2006-05-10 Hagemann Robert (SVP & Chief Financial Officer) Sale 32,312 58.25 1,882,206
2006-02-22 Peters Robert E (VP, Sales & Marketing) Sale 57,647 53.15 3,063,822
2006-02-22 Peters Robert E (VP, Sales & Marketing) Option Ex 69,767 30.37 2,118,544
2005-05-16 Flaherty James F Iii Sale 5,000 106.26 531,285
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of DGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Quest Diagnostics Inc (symbol DGX, CIK number 1022079) see the Securities and Exchange Commission (SEC) website.